A. M. J. Wensing
AuthID: R-00F-HYG
11
TITLE: Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management
AUTHORS: Wensing, AMJ; van de Vijver, DA; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; De Luca, A; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hemmer, R; Hoepelman, A; Horban, A; Korn, K; Kucherer, C; Leitner, T; ...More
PUBLISHED: 2005, SOURCE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 192, ISSUE: 6
AUTHORS: Wensing, AMJ; van de Vijver, DA; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; De Luca, A; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hemmer, R; Hoepelman, A; Horban, A; Korn, K; Kucherer, C; Leitner, T; ...More
PUBLISHED: 2005, SOURCE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 192, ISSUE: 6
12
TITLE: Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors
AUTHORS: de Vijver, DV; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; de Coul, ELMO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, IM; Hemmer, R; Horban, A; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10
AUTHORS: de Vijver, DV; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; de Coul, ELMO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, IM; Hemmer, R; Horban, A; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10
INDEXED IN: 
WOS
WOS13
TITLE: Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; de Coul, ELMO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, IM; Hemmer, R; Horban, A; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10, ISSUE: 4
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, ML; Costagliola, D; de Coul, ELMO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, IM; Hemmer, R; Horban, A; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10, ISSUE: 4
INDEXED IN: WOS
WOS14
TITLE: Selective transmission of drug resistance mutations
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Asjo, B; Bruckova, M; Jorgensen, LB; Horban, A; Linka, M; Lazanas, M; Loveday, C; MacRae, E; Nielsen, C; Paraskevis, D; Poljak, M; Puchhammer Stockl, E; Ruiz, L; Schmit, JCC; Stanczak, G; Stanojevic, M; Vandamme, AM; Vercauteren, J; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Asjo, B; Bruckova, M; Jorgensen, LB; Horban, A; Linka, M; Lazanas, M; Loveday, C; MacRae, E; Nielsen, C; Paraskevis, D; Poljak, M; Puchhammer Stockl, E; Ruiz, L; Schmit, JCC; Stanczak, G; Stanojevic, M; Vandamme, AM; Vercauteren, J; ...More
PUBLISHED: 2005, SOURCE: 14th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 10
INDEXED IN: WOS
WOS15
TITLE: The calculated genetic barrier for drug resistance mutations in six different non-B subtypes and two CRFs in a large European dataset is largely similar to subtype B
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, MI; Costagliola, D; de Coul, EO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Grossman, Z; Hamouda, O; Hatzakis, A; ...More
PUBLISHED: 2004, SOURCE: 13th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 9, ISSUE: 4
AUTHORS: van de Vijver, DAMC; Wensing, AMJ; Angarano, G; Asjo, B; Balotta, C; Boeri, E; Camacho, R; Chaix, MI; Costagliola, D; de Coul, EO; de Luca, A; Maljkovic, I; de Mendoza, C; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Grossman, Z; Hamouda, O; Hatzakis, A; ...More
PUBLISHED: 2004, SOURCE: 13th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 9, ISSUE: 4
INDEXED IN: WOS
WOS16
TITLE: Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study
AUTHORS: Wensing, AMJ; van de Vijver, DAMC; Asjo, B; Balotta, C; Camacho, R; de Mendoza, C; Deroo, S; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, A; Horban, A; Korn, K; Kuecherer, C; Nielsen, C; Ormaasen, V; Perrin, L; Paraskevis, D; Puchhammer, E; ...More
PUBLISHED: 2003, SOURCE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, ISSUE: 3
AUTHORS: Wensing, AMJ; van de Vijver, DAMC; Asjo, B; Balotta, C; Camacho, R; de Mendoza, C; Deroo, S; Derdelinckx, I; Grossman, Z; Hamouda, O; Hatzakis, A; Hoepelman, A; Horban, A; Korn, K; Kuecherer, C; Nielsen, C; Ormaasen, V; Perrin, L; Paraskevis, D; Puchhammer, E; ...More
PUBLISHED: 2003, SOURCE: 12th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 8, ISSUE: 3
INDEXED IN: WOS
WOS